MedTrace Logo

Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder

NCT00540098 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2007-10-05

No results posted yet for this study

Summary

Efficacy and safety of a 10-weeks treatment protocol of paroxetine vs. placebo in combination with regular aerobic exercise (running) or regular relaxation training in the treatment of panic disorder.

Conditions

  • Panic Disorder

Interventions

DRUG

paroxetine + aerobic exercise

paroxetine, 40 mg once daily + regular aerobic exercise

DRUG

Paroxetine + relaxation

paroxetine, 40 mg once daily + regular relaxation training

DRUG

Placebo + aerobic exercise

placebo pill once daily + regular aerobic exercise

DRUG

Placebo + relaxation

placebo pill once daily + regular relaxation training

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • University of Göttingen

    lead OTHER

Principal Investigators

  • Borwin Bandelow, Prof, MD · University of Göttingen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-09-30
Completion
2005-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00540098 on ClinicalTrials.gov